Synergistic Effect of Doxazosin and Acarbose in Improving Metabolic Control in Patients with Impaired Glucose Tolerance

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.26, Iss.9, 2006-01, pp. : 529-539

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Doxazosin + acarbose for improving glycaemic control in IGT

Inpharma, Vol. 1, Iss. 1553, 2006-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Acarbose prevents CVD, hypertension in impaired glucose tolerance

Inpharma, Vol. 1, Iss. 1398, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Post-Marketing Surveillance of Acarbose Treatment in Patients with Type 2 Diabetes Mellitus and Subjects with Impaired Glucose Tolerance in China

By Pan Chang-Yu

Clinical Drug Investigation, Vol. 27, Iss. 6, 2007-01 ,pp. : 397-405

Adis International

Access to resources Recommend Favorite

Effect of Cilostazol on Lipid, Uric Acid and Glucose Metabolism in Patients with Impaired Glucose Tolerance or Type 2 Diabetes Mellitus: A Double-Blind, Placebo-Controlled Study

By Toyota T.

Clinical Drug Investigation, Vol. 21, Iss. 5, 2001-01 ,pp. : 325-335

Adis International

Access to resources Recommend Favorite

Potential of -Glucosidase Inhibitors in Elderly Patients with Diabetes Mellitus and Impaired Glucose Tolerance

By Rabasa-Lhoret R. Chiasson L.

Drugs & Aging, Vol. 13, Iss. 2, 1998-08 ,pp. : 131-143

Adis International

Access to resources Recommend Favorite